Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Adaptation of the Tool to Estimate Patient Costs Questionnaire into Indonesian Context for Tuberculosis-affected Households

ACTA MEDICA INDONESIANA · Vol. 50 No. 1 (2018)

ISSN
2338-2732, 0125-9326
Terbit
2018-04-20
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: Indonesia is the second-highest country for tuberculosis (TB) incidence worldwide. Hence, it urgently requires improvements and innovations beyond the strategies that are currently being implemented throughout the country. One fundamental step in monitoring its progress is by preparing a validated tool to measure total patient costs and catastrophic total costs. The World Health Organization (WHO) recommends using a version of the generic questionnaire that has been adapted to the local cultural context in order to interpret findings correctly. This study is aimed to adapt the Tool to Estimate Patient Costs questionnaire into the Indonesian context, which measures total costs and catastrophic total costs for tuberculosis-affected households. Methods: the tool was adapted using best-practice guidelines. On the basis of a pre-test performed in a previous study (referred to as Phase 1 Study), we refined the adaptation process by comparing it with the generic tool introduced by the WHO. We also held an expert committee review and performed pre-testing by interviewing 30 TB patients. After pre-testing, the tool was provided with complete explanation sheets for finalization. Results: seventy-two major changes were made during the adaptation process including changing the answer choices to match the Indonesian context, refining the flow of questions, deleting questions, changing some words and restoring original questions that had been changed in Phase 1 Study. Participants indicated that most questions were clear and easy to understand. To address recall difficulties by the participants, we made some adaptations to obtain data that might be missing, such as tracking data to medical records, developing a proxy of costs and guiding interviewers to ask for a specific value when participants were uncertain about the estimated market value of property they had sold. Conclusion: the adapted Tool to Estimate Patient Costs in Bahasa Indonesia is comprehensive and ready for use in future studies on TB-related catastrophic costs and is suitable for monitoring progress to achieve the target of the End TB Strategy.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 178 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Sebelas Maret University
  • Universitas Teknologi Sumbawa
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Cosphiadi IrawanAfiliasi tidak diketahui3
Rahmat CahyanurAfiliasi tidak diketahui2
Achmad Fauzi KamalAfiliasi tidak diketahui2
Marlinda AdhamAfiliasi tidak diketahui2
Mardiah Suci HardiantiAfiliasi tidak diketahui2
Thariqah SalamahAfiliasi tidak diketahui2
Judhiastuty FebruhartantyAfiliasi tidak diketahui1
Fitya Safira BirahmatikaAfiliasi tidak diketahui1
Khalida FauziaAfiliasi tidak diketahui1
Indriya Laras PramesthiAfiliasi tidak diketahui1
Helda KhusunAfiliasi tidak diketahui1
Hera NurlitaAfiliasi tidak diketahui1
Ahmad Thohir HidayatAfiliasi tidak diketahui1
Teguh BudiharjoAfiliasi tidak diketahui1
Djoko PriyatnoAfiliasi tidak diketahui1
Anung SugihantonoAfiliasi tidak diketahui1
Sukman Tulus PutraAfiliasi tidak diketahui1
Sudigdo SatroasmoroAfiliasi tidak diketahui1
Suroto SurotoSebelas Maret University1
Lugyanti SukrismanAfiliasi tidak diketahui1
Al RasyidAfiliasi tidak diketahui1
Jusuf MisbachAfiliasi tidak diketahui1
Jan S PurbaAfiliasi tidak diketahui1
Ina S TimanAfiliasi tidak diketahui1
Efta YudiarsahAfiliasi tidak diketahui1
Djumhana AtmakusumahAfiliasi tidak diketahui1
Abdulmuthalib AbdulmuthalibAfiliasi tidak diketahui1
Nurjati Chaeranie SiregarAfiliasi tidak diketahui1
The Bin TeanAfiliasi tidak diketahui1
Lim Weng KongAfiliasi tidak diketahui1
Ong Choon KiatAfiliasi tidak diketahui1
Alida HarahapAfiliasi tidak diketahui1
Lisnawati LisnawatiUniversitas Teknologi Sumbawa1
Ahmad R. Handoyo UtomoAfiliasi tidak diketahui1
Lisnawati RachmadiAfiliasi tidak diketahui1
Achmad Rusdan Handoyo UtomoAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Adaptation of the Tool to Estimate Patient Costs Questionnaire into Indonesian Context for Tuberculosis-affected Households</dc:title>
	<dc:creator>Fuady, Ahmad</dc:creator>
	<dc:creator>Houweling, Tanja A</dc:creator>
	<dc:creator>Mansyur, Muchtaruddin</dc:creator>
	<dc:creator>Richardus, Jan H</dc:creator>
	<dc:subject xml:lang="en-US">tuberculosis</dc:subject>
	<dc:subject xml:lang="en-US">patient costs</dc:subject>
	<dc:subject xml:lang="en-US">catastrophic costs</dc:subject>
	<dc:subject xml:lang="en-US">adaptation</dc:subject>
	<dc:subject xml:lang="en-US">Indonesia</dc:subject>
	<dc:subject xml:lang="en-US">tuberculosis</dc:subject>
	<dc:description xml:lang="en-US">Background: Indonesia is the second-highest country for tuberculosis (TB) incidence worldwide. Hence, it urgently requires improvements and innovations beyond the strategies that are currently being implemented throughout the country. One fundamental step in monitoring its progress is by preparing a validated tool to measure total patient costs and catastrophic total costs. The World Health Organization (WHO) recommends using a version of the generic questionnaire that has been adapted to the local cultural context in order to interpret findings correctly. This study is aimed to adapt the Tool to Estimate Patient Costs questionnaire into the Indonesian context, which measures total costs and catastrophic total costs for tuberculosis-affected households. Methods: the tool was adapted using best-practice guidelines. On the basis of a pre-test performed in a previous study (referred to as Phase 1 Study), we refined the adaptation process by comparing it with the generic tool introduced by the WHO. We also held an expert committee review and performed pre-testing by interviewing 30 TB patients. After pre-testing, the tool was provided with complete explanation sheets for finalization. Results: seventy-two major changes were made during the adaptation process including changing the answer choices to match the Indonesian context, refining the flow of questions, deleting questions, changing some words and restoring original questions that had been changed in Phase 1 Study. Participants indicated that most questions were clear and easy to understand. To address recall difficulties by the participants, we made some adaptations to obtain data that might be missing, such as tracking data to medical records, developing a proxy of costs and guiding interviewers to ask for a specific value when participants were uncertain about the estimated market value of property they had sold. Conclusion: the adapted Tool to Estimate Patient Costs in Bahasa Indonesia is comprehensive and ready for use in future studies on TB-related catastrophic costs and is suitable for monitoring progress to achieve the target of the End TB Strategy.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2018-04-20</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/347</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 50 No. 1 (2018): Acta Medica Indonesiana; 3</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/347/pdf</dc:relation>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/347/pdf_1</dc:relation>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/347/pdf_2</dc:relation>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/347/pdf_3</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>